Sage Therapeutics to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 18, 2023--
Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, May 2, 2023 at 8:00 a.m. ET to review first quarter 2023 financial results and discuss recent business updates.
The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit. www.sagerx.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20230414005410/en/
CONTACT: Investor Contact
Helen Rubinstein
315-382-3979
helen.rubinstein@sagerx.com
Media Contact
Matthew Henson
917-930-7147
matthew.henson@sagerx.com
KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: Sage Therapeutics, Inc.
Copyright Business Wire 2023.
PUB: 04/18/2023 06:30 AM/DISC: 04/18/2023 06:31 AM
http://www.businesswire.com/news/home/20230414005410/en
